Current status and prospect of PET-related imaging radiomics in lung cancer

Lung cancer is highly aggressive, which has a high mortality rate. Major types encompass lung adenocarcinoma, lung squamous cell carcinoma, lung adenosquamous carcinoma, small cell carcinoma, and large cell carcinoma. Lung adenocarcinoma and lung squamous cell carcinoma together account for more tha...

Descripció completa

Dades bibliogràfiques
Autors principals: Xin Tang, Fan Wu, Xiaofen Chen, Shengli Ye, Zhongxiang Ding
Format: Article
Idioma:English
Publicat: Frontiers Media S.A. 2023-12-01
Col·lecció:Frontiers in Oncology
Matèries:
Accés en línia:https://www.frontiersin.org/articles/10.3389/fonc.2023.1297674/full
_version_ 1827580963857629184
author Xin Tang
Fan Wu
Xiaofen Chen
Shengli Ye
Zhongxiang Ding
author_facet Xin Tang
Fan Wu
Xiaofen Chen
Shengli Ye
Zhongxiang Ding
author_sort Xin Tang
collection DOAJ
description Lung cancer is highly aggressive, which has a high mortality rate. Major types encompass lung adenocarcinoma, lung squamous cell carcinoma, lung adenosquamous carcinoma, small cell carcinoma, and large cell carcinoma. Lung adenocarcinoma and lung squamous cell carcinoma together account for more than 80% of cases. Diverse subtypes demand distinct treatment approaches. The application of precision medicine necessitates prompt and accurate evaluation of treatment effectiveness, contributing to the improvement of treatment strategies and outcomes. Medical imaging is crucial in the diagnosis and management of lung cancer, with techniques such as fluoroscopy, computed radiography (CR), digital radiography (DR), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)/CT, and PET/MRI being essential tools. The surge of radiomics in recent times offers fresh promise for cancer diagnosis and treatment. In particular, PET/CT and PET/MRI radiomics, extensively studied in lung cancer research, have made advancements in diagnosing the disease, evaluating metastasis, predicting molecular subtypes, and forecasting patient prognosis. While conventional imaging methods continue to play a primary role in diagnosis and assessment, PET/CT and PET/MRI radiomics simultaneously provide detailed morphological and functional information. This has significant clinical potential value, offering advantages for lung cancer diagnosis and treatment. Hence, this manuscript provides a review of the latest developments in PET-related radiomics for lung cancer.
first_indexed 2024-03-08T22:28:38Z
format Article
id doaj.art-b985c9f1c87d4e06a4b521df87834166
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-08T22:28:38Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-b985c9f1c87d4e06a4b521df878341662023-12-18T07:38:05ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-12-011310.3389/fonc.2023.12976741297674Current status and prospect of PET-related imaging radiomics in lung cancerXin Tang0Fan Wu1Xiaofen Chen2Shengli Ye3Zhongxiang Ding4Department of Radiology, Hangzhou Wuyunshan Hospital (Hangzhou Health Promotion Research Institute), Hangzhou, ChinaDepartment of Nuclear Medicine and Radiology, Shulan Hangzhou Hospital affiliated to Shulan International Medical College of Zhejiang Shuren University, Hangzhou, ChinaDepartment of Radiology, Hangzhou Wuyunshan Hospital (Hangzhou Health Promotion Research Institute), Hangzhou, ChinaDepartment of Nuclear Medicine and Radiology, Shulan Hangzhou Hospital affiliated to Shulan International Medical College of Zhejiang Shuren University, Hangzhou, ChinaDepartment of Radiology, Hangzhou First People’s Hospital, Hangzhou, ChinaLung cancer is highly aggressive, which has a high mortality rate. Major types encompass lung adenocarcinoma, lung squamous cell carcinoma, lung adenosquamous carcinoma, small cell carcinoma, and large cell carcinoma. Lung adenocarcinoma and lung squamous cell carcinoma together account for more than 80% of cases. Diverse subtypes demand distinct treatment approaches. The application of precision medicine necessitates prompt and accurate evaluation of treatment effectiveness, contributing to the improvement of treatment strategies and outcomes. Medical imaging is crucial in the diagnosis and management of lung cancer, with techniques such as fluoroscopy, computed radiography (CR), digital radiography (DR), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)/CT, and PET/MRI being essential tools. The surge of radiomics in recent times offers fresh promise for cancer diagnosis and treatment. In particular, PET/CT and PET/MRI radiomics, extensively studied in lung cancer research, have made advancements in diagnosing the disease, evaluating metastasis, predicting molecular subtypes, and forecasting patient prognosis. While conventional imaging methods continue to play a primary role in diagnosis and assessment, PET/CT and PET/MRI radiomics simultaneously provide detailed morphological and functional information. This has significant clinical potential value, offering advantages for lung cancer diagnosis and treatment. Hence, this manuscript provides a review of the latest developments in PET-related radiomics for lung cancer.https://www.frontiersin.org/articles/10.3389/fonc.2023.1297674/fulllung cancerradiomicspositron emission tomography/magnetic resonance imagingpositron emission tomography/computed tomographyreview
spellingShingle Xin Tang
Fan Wu
Xiaofen Chen
Shengli Ye
Zhongxiang Ding
Current status and prospect of PET-related imaging radiomics in lung cancer
Frontiers in Oncology
lung cancer
radiomics
positron emission tomography/magnetic resonance imaging
positron emission tomography/computed tomography
review
title Current status and prospect of PET-related imaging radiomics in lung cancer
title_full Current status and prospect of PET-related imaging radiomics in lung cancer
title_fullStr Current status and prospect of PET-related imaging radiomics in lung cancer
title_full_unstemmed Current status and prospect of PET-related imaging radiomics in lung cancer
title_short Current status and prospect of PET-related imaging radiomics in lung cancer
title_sort current status and prospect of pet related imaging radiomics in lung cancer
topic lung cancer
radiomics
positron emission tomography/magnetic resonance imaging
positron emission tomography/computed tomography
review
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1297674/full
work_keys_str_mv AT xintang currentstatusandprospectofpetrelatedimagingradiomicsinlungcancer
AT fanwu currentstatusandprospectofpetrelatedimagingradiomicsinlungcancer
AT xiaofenchen currentstatusandprospectofpetrelatedimagingradiomicsinlungcancer
AT shengliye currentstatusandprospectofpetrelatedimagingradiomicsinlungcancer
AT zhongxiangding currentstatusandprospectofpetrelatedimagingradiomicsinlungcancer